Figure 1From: Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-lifeSelf-assessed QoL (EORTC-C30) before and during VMAT for Global Health Status, and physical, emotional and role functioning.Back to article page